Angel Diaz-Ponferrada

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Clinical features and therapeutic requirements of perianal disease in adult patients with ulcerative colitis: the PERICO study of the ENEIDA registry.

Clinical features and therapeutic requirements of perianal disease in adult patients with ulcerative colitis: the PERICO study of the ENEIDA registry.

Journal: Inflammatory bowel diseases

Published: March 15, 2026

Impact of Prior Biologic Mechanism of Action on Anti-TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study.

Impact of Prior Biologic Mechanism of Action on Anti-TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study.

Journal: Alimentary pharmacology & therapeutics

Published: March 14, 2026

Multicenter Spanish study on vedolizumab intravenous to subcutaneous switch in patients with inflammatory bowel disease in clinical remission.

Multicenter Spanish study on vedolizumab intravenous to subcutaneous switch in patients with inflammatory bowel disease in clinical remission.

Journal: Revista espanola de enfermedades digestivas

Published: September 29, 2025

Endoscopic diverticulotomy on Zenker's diverticulum with SB knife junior type endoscopic scissors. Safety profile in esophageal muco-myotomy.

Endoscopic diverticulotomy on Zenker's diverticulum with SB knife junior type endoscopic scissors. Safety profile in esophageal muco-myotomy.

Journal: Revista espanola de enfermedades digestivas

Published: September 29, 2025

Multicenter Spanish study on vedolizumab intravenous to subcutaneous switch in patients with inflammatory bowel disease in clinical remission.

Multicenter Spanish study on vedolizumab intravenous to subcutaneous switch in patients with inflammatory bowel disease in clinical remission.

Journal: Revista espanola de enfermedades digestivas

Published: September 29, 2025

Influence of Familial Inflammatory Bowel Disease History on the Use of Immunosuppressants, Biological Agents and Surgery in Patients with Pediatric-Onset of the Disease in the Era of Biological Therapies. Results from the ENEIDA Registry.

Influence of Familial Inflammatory Bowel Disease History on the Use of Immunosuppressants, Biological Agents and Surgery in Patients with Pediatric-Onset of the Disease in the Era of Biological Therapies. Results from the ENEIDA Registry.

Journal: Journal of clinical medicine

Published: April 01, 2025

Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA.

Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA.

Journal: Alimentary pharmacology & therapeutics

Published: March 03, 2025

Esophagitis dissecans superficialis: an unusual desquamative disorder.

Esophagitis dissecans superficialis: an unusual desquamative disorder.

Journal: Revista espanola de enfermedades digestivas

Published: January 20, 2025

Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study.

Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study.

Journal: Alimentary pharmacology & therapeutics

Published: June 09, 2024

Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence.

Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence.

Journal: The American journal of gastroenterology

Published: June 07, 2024

Heterotaxia syndrome: when almost nothing is as it should be.

Heterotaxia syndrome: when almost nothing is as it should be.

Journal: Gastroenterologia y hepatologia

Published: May 06, 2024

Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU.

Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: March 29, 2024

Showing 1-12 of 23

Last Updated: 09/26/2026